THE ROLE OF INTELLECTUAL PROPERTY IN THE DEVELOPMENT OF BIOPRINTING TECHNOLOGY IN INDIA: CHALLENGES AND LIABILITIES
AUTHOR – MRS. DIPALI MOHAN KHALATE, LLM STUDENT AT MODERN LAW COLLEGE, SAVITRIBAI PHULE PUNE UNIVERSITY
BEST CITATION – MRS. DIPALI MOHAN KHALATE, THE ROLE OF INTELLECTUAL PROPERTY IN THE DEVELOPMENT OF BIOPRINTING TECHNOLOGY IN INDIA: CHALLENGES AND LIABILITIES, INDIAN JOURNAL OF LEGAL REVIEW (IJLR), 5 (12) OF 2025, PG. 1008-1019, APIS – 3920 – 0001 & ISSN – 2583-2344
Abstract
Bioprinting, an innovative combination of biotechnology and additive manufacturing, has emerged as a transformative technology in healthcare, enabling the fabrication of functional tissues, organs, and patient-specific implants. The implementation of the aforementioned, however, introduces unique intellectual property (IP) challenges that extend beyond conventional biotechnology. The study explores three critical areas of concern: IP protection for bioprinting hardware and bioinks, ownership and ethical management of digital files derived from biological data, and the implications of commercializing bioprinted tissues and organs. Employing a multidisciplinary approach, the paper analyzes existing IP frameworks, [1]highlights their limitations when applied to bioprinting, and examines ethical dilemmas, such as ownership of bioprinted human tissues and the commodification of biological innovations. Findings suggest that current IP laws inadequately address the complexities of bioprinting, particularly in managing the intersection of proprietary technologies[2] and ethical considerations. The study underscores the need for adaptive legal and ethical frameworks to balance innovation with equitable access and sustainability. Recommendations include the development of tailored IP policies for bioprinting and enhanced international collaboration to harmonize legal protections across jurisdictions. This work aims to provide a comprehensive foundation for stakeholders to navigate the rapidly evolving landscape of bioprinting IP. Keywords: bioprinting; intellectual property; bioinks; bioprinting hardware; digital design files; ethical considerations; patentability; regulatory frameworks; personalized medicine; regenerative medicine Introduction : Additive manufacturing, or 3D printing, constitutes a groundbreaking method of production that has the capacity to profoundly alter numerous[3] industries. Fundamentally, 3D printing is the layer by-layer construction of three-dimensional objects from digital models, employing a diverse array of materials, including plastics, metals, ceramics, and even biological substances1. This technology has significantly evolved since its introduction in the 1980s, transforming from a specialized tool for rapid prototyping into a mainstream manufacturing process that facilitates the creation of complex geometries that would be challenging, if not impossible, to achieve with conventional subtractive manufacturing techniques2. The disruptive potential of 3D printing spans multiple sectors, including aerospace, automotive, healthcare, fashion, and construction, among others. In the aerospace sector,[4] 3D printing enables the fabrication of lightweight components that improve fuel efficiency and minimize waste, as it permits the design of intricate structures that optimize strength-to-weight ratios 3. In the automotive sector, manufacturers are increasingly utilizing additive manufacturing for both prototype and the production of customized components, thereby reducing lead times and costs associated with conventional manufacturing methods. Bioprinting, an emerging technology that integrates additive manufacturing with biological sciences, is positioned at the forefront of [5]transformative innovations in healthcare and biomedical research . This process entails the precise, layer-by-layer deposition of bioinks—comprising living cells, biomaterials, and other biologically relevant substances utilized to fabricate complex, three dimensional tissue structures that emulate the morphology and functionality of native biological tissues
[1] Pratap Devarapalli & Dara Ajay, The Impact of 3D Bioprinting Innovation on IP Ecosystem and Patent Law: An Indian and US Perspective, in Science, Technology and Innovation Ecosystem: An Indian and Global Perspective (Springer, 2024) pp. 197–210
[2] Dr. Soumya Kanti Ghosh & Unnat P. Pandit, Patent Revolution in India, IPR Newsletter, Intellectual Property India (Feb 2024) 1–6
[3] Akshat Mehta & Nancy Saroha, Traversing India’s Intellectual Property Landscape: Insights from the International IP Index, Bar & Bench (13 Apr 2024).
[4] WIPO, 3D Printing and IP: Trends and Challenges, World Intellectual Property Organization (2023).
[5] Vidhi Centre for Legal Policy, Reimagining India’s IP Framework for Emerging Technologies, Policy Brief (2022)